MILES HARTMAN: Open Payments
NPI 1760948574 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 11 payments from 5 companies in 2025. Trend: 2023 $723 · 2024 $142 · 2025 $594
Food & beverage: $483Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $206 |
| Teva Pharmaceuticals USA, Inc. | 3 | $205 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Alkermes, Inc. | 1 | $21 |
Products named: REXULTI, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, UZEDY, ARISTADA.
Industry payments across MO — which companies pay providers there.
